Novavax, Inc.
NVAX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,223,608 | $483,686 | $803,721 | $10,644,408 |
| - Cash | $530,230 | $568,505 | $1,336,883 | $1,515,116 |
| + Debt | $230,419 | $229,081 | $549,781 | $453,991 |
| Enterprise Value | $923,797 | $144,262 | $16,619 | $9,583,283 |
| Revenue | $682,162 | $556,382 | $1,598,951 | $197,581 |
| % Growth | 22.6% | -65.2% | 709.3% | – |
| Gross Profit | $479,423 | $212,614 | $696,312 | $197,581 |
| % Margin | 70.3% | 38.2% | 43.5% | 100% |
| EBITDA | -$108,044 | -$487,390 | -$604,713 | -$1,680,748 |
| % Margin | -15.8% | -87.6% | -37.8% | -850.7% |
| Net Income | -$187,499 | -$545,062 | -$657,939 | -$1,743,751 |
| % Margin | -27.5% | -98% | -41.1% | -882.5% |
| EPS Diluted | -1.23 | -5.41 | -8.42 | -23.44 |
| % Growth | 77.3% | 35.7% | 64.1% | – |
| Operating Cash Flow | -$87,263 | -$713,967 | -$415,937 | $322,946 |
| Capital Expenditures | -$13,057 | -$58,806 | -$92,985 | -$57,486 |
| Free Cash Flow | -$100,320 | -$772,773 | -$508,922 | $265,460 |